Clinical trials
Recruiting Phase 1/2 Esophageal Squamous Cell Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 3 |
| AP Biosciences Inc. | 1 |
| Alentis Therapeutics AG | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| DualityBio Inc. | 1 |
| InduPro, Inc. | 1 |
| Neonc Technologies, Inc. | 1 |
| Radiopharm Theranostics, Ltd | 1 |
| Rapa Therapeutics LLC | 1 |
| Shanghai Chest Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Squamous Cell Carcinoma | 16 |
| Squamous Cell Carcinoma of Head and Neck | 10 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Uterine Cervical Neoplasms | 5 |
| Small Cell Lung Carcinoma | 4 |
| Esophageal Neoplasms | 3 |
| Melanoma | 3 |
| Carcinoma, Squamous Cell | 2 |
| Colorectal Neoplasms | 2 |
| Endometrial Neoplasms | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.